[Interaction between inhaled corticosteroids and long-acting beta-2-agonists].
Kardos
P
P
Institut Gemeinschaftspraxis und Zentrum für Pneumologie, Allergologie & Schlafmedizin, Klinik Maingau. pkardos@aol.com
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D000328:Adult; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects / Q000276:immunology; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D004357:Drug Synergism; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood; D007958:Leukocyte Count; D018375:Neutrophil Activation / Q000187:drug effects / Q000276:immunology; D016032:Randomized Controlled Trials as Topic
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D018836:Inflammation Mediators